Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
9.79
+0.32 (3.38%)
At close: Jun 26, 2026, 4:00 PM EDT
10.00
+0.21 (2.15%)
After-hours: Jun 26, 2026, 7:52 PM EDT
Candel Therapeutics Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Candel Therapeutics stock have an average target of 21.5, with a low estimate of 9.00 and a high estimate of 30. The average target predicts an increase of 119.61% from the current stock price of 9.79.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Candel Therapeutics stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 8 | 8 | 7 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 9 | 9 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $23 | Buy | Maintains | $23 | +134.93% | Jun 2, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Maintains $9 | Hold | Maintains | $9 | -8.07% | Jun 1, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $25 | Buy | Maintains | $25 | +155.36% | May 18, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Reiterates $16 | Buy | Reiterates | $16 | +63.43% | May 14, 2026 |
Unknown Analyst Cantor Fitzgerald No rating | Cantor Fitzgerald | Buy Initiates $30 | Buy | Initiates | $30 | +206.44% | Apr 20, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
52.65M
EPS This Year
-0.87
from -0.88
EPS Next Year
0.22
from -0.87
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | 128.8M | |
| Avg | n/a | 52.6M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | 594.6% |
| Avg | - | 222.1% |
| Low | - | -24.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.74 | 0.22 | |
| Avg | -0.87 | 0.22 | |
| Low | -1.11 | 0.22 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.